Mini-laparotomy Versus Mini Lumbotomy (RAMini)

September 17, 2018 updated by: Central Hospital, Nancy, France

Prospective Randomized Study of Two Aortic Surgical Approaches: Mini-laparotomy Versus Mini Lumbotomy

This study aims to compare the results of two mini invasive surgical approaches in abdominal aortic surgery: mini lumbotomy with retroperitoneal approach versus mini laparotomy with transperitoneal approach. Respiratory and renal functions and recovery of intestinal transit will be assessed after 30 days.

The secondary purpose of this study is to assess the life quality and morbi-mortality at 30 days, as well as at 6 and 12 months.

Study Overview

Detailed Description

Following abdominal aortic surgery, post-operative outcomes are considered favorable with a rapid recovery of respiratory, renal functions and intestinal transit, with limited cardiac events. Complications are still frequent after the classic open abdominal surgery.

In abdominal aortic surgery, "mini" abdominal incision has been proposed as an alternative to the classic large surgical approach.

Two mini surgical approaches are possible: mini lumbotomy with retroperitoneal approach, and mini laparatomy with transperitoneal approach.

Previous studies have only compared classic versus mini surgical approaches and many are retrospectives studies. Pain control through the mini-incision surgery allowed early mobilization of patients, improved lung function, reduced muscle loss, and favoured intestinal motility.

So far, no study has compared the results of two mini invasive aortic approaches.

The aim of this prospective randomized study is to compare two mini-invasive surgical approaches and to determine which of them allows the improvement of surgical outcomes with less morbi-mortality.

Study Type

Interventional

Enrollment (Anticipated)

206

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Elective abdominal aortic repair.
  • Abdominal aneurysm or occlusive aortic disease requiring intervention.
  • Written consent previously provided by the patient.
  • Affiliation to social security.
  • Preliminary medical examination.

Exclusion Criteria:

  • Hostile abdomen.
  • Juxta renal abdominal aortic aneurysm.
  • Aneurysmal extension to the iliac arteries.
  • Concomitant visceral arteries lesions.
  • Urgent surgery.
  • Contraindication to surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Mini laparotomy
Patients with surgical indication to mini invasive aortic repair will be operated after randomisation with transperitoneal approach
The patient will be positioned supine. After induction of general anesthesia, a median umbilical incision will be performed. The average length of the incision of the laparotomy will be 10 cm (8-12 cm). The small intestine will be then mobilized medially and held by an orthostatic retractor. Arterial dissection and control as well as bypasses will be performed according to the conventional technique. In case of occlusive disease of the iliac arteries, femoral site will be selected to achieve the distal anastomoses of the bifurcated prosthetic graft.
Other Names:
  • transperitoneal approach
Other: Mini lumbotomy
Patients with surgical indication to mini invasive aortic repair will be operated after randomisation with retroperitoneal approach

After induction of general anesthesia, the patient will be positioned in right lateral decubitus at 45° of the table plane. The incision will be performed from the tip of the eleventh rib with a slightly sloping path to the outer edge of the rectus muscle. The average length of the incision of the laparotomy will be 10 cm (8-12 cm).

Abdominal aorta will be approached retroperitoneally. Arterial dissection and control as well as bypasses will be performed according to the conventional retroperitoneal technique. In case of occlusive disease of the iliac arteries, femoral site will be selected to achieve the distal anastomoses of the bifurcated prosthetic graft.

Other Names:
  • retro-peritoneal approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory recovery
Time Frame: day 30
evaluated with respiratory function test (Sniff nasal inspiratory pressure, SNIP test)
day 30
Renal recovery
Time Frame: day 30
evaluated by blood creatinine level, uremia and kalemia
day 30
Intestinal transit recovery
Time Frame: day 30
evaluated by reapparition of gas and transit
day 30

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory recovery
Time Frame: day 1
evaluated by SNIP test
day 1
Respiratory recovery
Time Frame: day 3
evaluated by SNIP test
day 3
Respiratory recovery
Time Frame: day 5
evaluated by SNIP test
day 5
Renal recovery
Time Frame: day 1
evaluated by creatinine clearance, uremia and kaliemia
day 1
Renal recovery
Time Frame: day 3
evaluated by creatinine clearance, uremia and kaliemia
day 3
Renal recovery
Time Frame: day 5
evaluated by creatinine clearance, uremia and kaliemia
day 5
Intestinal recovery
Time Frame: day 1
assessment of intestinal transit (stool emission)
day 1
Intestinal recovery
Time Frame: day 3
assessment of intestinal transit (stool emission)
day 3
Intestinal recovery
Time Frame: day 5
assessment of intestinal transit (stool emission)
day 5
Post-operative pain assessment
Time Frame: day 1
with VAS scale
day 1
Post-operative pain assessment
Time Frame: day 3
with VAS scale
day 3
Post-operative pain assessment
Time Frame: day 5
with VAS scale
day 5
Quality of life assessment
Time Frame: after 6 months
by using SF-12 questionnaire
after 6 months
Quality of life assessment
Time Frame: after 1 year
by using SF-12 questionnaire
after 1 year
Morbi-mortality
Time Frame: after 6 months
evaluated by EQ-5D questionnaire
after 6 months
Morbi-mortality
Time Frame: after 1 year
evaluated by EQ-5D questionnaire
after 1 year
Morbi-mortality
Time Frame: day 30
evaluated by non-recovery of functions, eventration and death
day 30

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nicla Settembre, MD, PhD, Department of vascular and endovascular surgery. Nancy University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2018

Primary Completion (Anticipated)

January 1, 2019

Study Completion (Anticipated)

January 1, 2020

Study Registration Dates

First Submitted

July 1, 2016

First Submitted That Met QC Criteria

August 30, 2016

First Posted (Estimate)

September 5, 2016

Study Record Updates

Last Update Posted (Actual)

September 18, 2018

Last Update Submitted That Met QC Criteria

September 17, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Aortic Aneurysms

Clinical Trials on mini laparotomy

3
Subscribe